206 related articles for article (PubMed ID: 17049585)
1. Endothelial protein C receptor plasma levels increase in chronic liver disease, while thrombomodulin plasma levels increase only in hepatocellular carcinoma.
Biguzzi E; Franchi F; Bucciarelli P; Colombo M; Romeo R
Thromb Res; 2007; 120(2):289-93. PubMed ID: 17049585
[TBL] [Abstract][Full Text] [Related]
2. Protein C depletion early after trauma increases the risk of ventilator-associated pneumonia.
Cohen MJ; Bir N; Rahn P; Dotson R; Brohi K; Chesebro BB; Mackersie R; Carles M; Wiener-Kronish J; Pittet JF
J Trauma; 2009 Dec; 67(6):1176-81. PubMed ID: 20009664
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
[TBL] [Abstract][Full Text] [Related]
4. Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis.
Henry L; Lavabre-Bertrand T; Vercambre L; Ramos J; Carillo S; Guiraud I; Pouderoux P; Bismuth M; Valats JC; Demattei C; Duny Y; Chaze I; Funakoshi N; Bureau JP; Daurès JP; Blanc P
Gut; 2009 Jun; 58(6):833-8. PubMed ID: 19201777
[TBL] [Abstract][Full Text] [Related]
5. Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients.
Jin-no K; Tanimizu M; Hyodo I; Nishikawa Y; Hosokawa Y; Endo H; Doi T; Mandai K; Ishitsuka H
Cancer; 1998 Apr; 82(7):1260-7. PubMed ID: 9529017
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma.
Massironi S; Fraquelli M; Paggi S; Sangiovanni A; Conte D; Sciola V; Ciafardini C; Colombo M; Peracchi M
Dig Liver Dis; 2009 Jan; 41(1):31-5. PubMed ID: 18762462
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cells.
Nan B; Yang H; Yan S; Lin PH; Lumsden AB; Yao Q; Chen C
Surgery; 2005 Aug; 138(2):212-22. PubMed ID: 16153429
[TBL] [Abstract][Full Text] [Related]
9. Soluble endothelial protein C receptor level in children with sepsis.
Kendirli T; Ince E; Ciftci E; Doğru U; Eğin Y; Akar N
Pediatr Hematol Oncol; 2009 Sep; 26(6):432-8. PubMed ID: 19657993
[TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
Zhou Q; Liang LJ; Peng BG; Zhen YY
Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
[TBL] [Abstract][Full Text] [Related]
11. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
12. Effects of shear stress on protein C activation, EPCR expression and TM expression in endothelial cells.
Jun P; Huangqing C; Xiaoheng L; Ruheng L; Xiaohong Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Apr; 26(2):303-9. PubMed ID: 19499791
[TBL] [Abstract][Full Text] [Related]
13. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.
Tripodi A; Primignani M; Chantarangkul V; Dell'Era A; Clerici M; de Franchis R; Colombo M; Mannucci PM
Gastroenterology; 2009 Dec; 137(6):2105-11. PubMed ID: 19706293
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
15. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease.
Gressner OA; Jafari S; Erkens M; Gao C; Stanzel S; Gressner AM
Clin Chim Acta; 2009 May; 403(1-2):188-93. PubMed ID: 19281805
[TBL] [Abstract][Full Text] [Related]
17. Variations in the thrombomodulin and endothelial protein C receptor genes in couples with recurrent miscarriage.
Kaare M; Ulander VM; Painter JN; Ahvenainen T; Kaaja R; Aittomäki K
Hum Reprod; 2007 Mar; 22(3):864-8. PubMed ID: 17099210
[TBL] [Abstract][Full Text] [Related]
18. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma.
Moriyama A; Masumoto A; Nanri H; Tabaru A; Unoki H; Imoto I; Ikeda M; Otsuki M
Am J Gastroenterol; 1997 Sep; 92(9):1520-3. PubMed ID: 9317076
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M
J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253
[TBL] [Abstract][Full Text] [Related]
20. Increased serum levels of macrophage inflammatory protein-3alpha in hepatocellular carcinoma: relationship with clinical factors and prognostic importance during therapy.
Yamauchi K; Akbar SM; Horiike N; Michitaka K; Onji M
Int J Mol Med; 2003 May; 11(5):601-5. PubMed ID: 12684696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
